These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 10389937)
1. High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas. Tang XX; Evans AE; Zhao H; Cnaan A; London W; Cohn SL; Brodeur GM; Ikegaki N Clin Cancer Res; 1999 Jun; 5(6):1491-6. PubMed ID: 10389937 [TBL] [Abstract][Full Text] [Related]
2. Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas. Tang XX; Evans AE; Zhao H; Cnaan A; Brodeur GM; Ikegaki N Med Pediatr Oncol; 2001 Jan; 36(1):80-2. PubMed ID: 11464911 [TBL] [Abstract][Full Text] [Related]
3. Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Tang XX; Zhao H; Robinson ME; Cohen B; Cnaan A; London W; Cohn SL; Cheung NK; Brodeur GM; Evans AE; Ikegaki N Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10936-41. PubMed ID: 10984508 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastoma. Tang XX; Zhao H; Robinson ME; Cnaan A; London W; Cohn SL; Cheung NK; Brodeur GM; Evans AE; Ikegaki N Med Pediatr Oncol; 2000 Dec; 35(6):656-8. PubMed ID: 11107140 [TBL] [Abstract][Full Text] [Related]
5. Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma. Tang XX; Brodeur GM; Campling BG; Ikegaki N Clin Cancer Res; 1999 Feb; 5(2):455-60. PubMed ID: 10037197 [TBL] [Abstract][Full Text] [Related]
6. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914 [TBL] [Abstract][Full Text] [Related]
7. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma. Eggert A; Ikegaki N; Liu XG; Brodeur GM Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551 [TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma. Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma. Kramer K; Gerald W; LeSauteur L; Uri Saragovi H; Cheung NK Clin Cancer Res; 1996 Aug; 2(8):1361-7. PubMed ID: 9816308 [TBL] [Abstract][Full Text] [Related]
11. Expression of KIT and PDGFR is associated with a good prognosis in neuroblastoma. Shimada A; Hirato J; Kuroiwa M; Kikuchi A; Hanada R; Wakai K; Hayashi Y Pediatr Blood Cancer; 2008 Feb; 50(2):213-7. PubMed ID: 17941064 [TBL] [Abstract][Full Text] [Related]
12. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas. Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588 [TBL] [Abstract][Full Text] [Related]
13. De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene. Ikegaki N; Gotoh T; Kung B; Riceberg JS; Kim DY; Zhao H; Rappaport EF; Hicks SL; Seeger RC; Tang XX Clin Cancer Res; 2007 Oct; 13(20):6001-9. PubMed ID: 17947461 [TBL] [Abstract][Full Text] [Related]
14. The studies on the correlation for gene expression of tyrosine-kinase receptors and vascular endothelial growth factor in human neuroblastomas. Zhang J; Zheng Y; Wang Y; Tong H J Pediatr Hematol Oncol; 2010 Apr; 32(3):180-4. PubMed ID: 20186105 [TBL] [Abstract][Full Text] [Related]
15. Loss of EphB6 expression in metastatic melanoma. Hafner C; Bataille F; Meyer S; Becker B; Roesch A; Landthaler M; Vogt T Int J Oncol; 2003 Dec; 23(6):1553-9. PubMed ID: 14612926 [TBL] [Abstract][Full Text] [Related]
16. Expression of TrkC in favorable human neuroblastomas. Yamashiro DJ; Nakagawara A; Ikegaki N; Liu XG; Brodeur GM Oncogene; 1996 Jan; 12(1):37-41. PubMed ID: 8552397 [TBL] [Abstract][Full Text] [Related]
17. Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis--a study of 106 primary neuroblastomas treated in a single institute. Hishiki T; Saito T; Terui K; Sato Y; Takenouchi A; Yahata E; Ono S; Nakagawara A; Kamijo T; Nakamura Y; Matsunaga T; Yoshida H J Pediatr Surg; 2010 Dec; 45(12):2293-8. PubMed ID: 21129533 [TBL] [Abstract][Full Text] [Related]
18. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study. George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152 [TBL] [Abstract][Full Text] [Related]
19. Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer. Kataoka H; Tanaka M; Kanamori M; Yoshii S; Ihara M; Wang YJ; Song JP; Li ZY; Arai H; Otsuki Y; Kobayashi T; Konno H; Hanai H; Sugimura H J Cancer Res Clin Oncol; 2002 Jul; 128(7):343-8. PubMed ID: 12136247 [TBL] [Abstract][Full Text] [Related]
20. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma. Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]